|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123 JPY | 0.00% |
|
-3.15% | -8.89% |
| Apr. 01 | Chiome Bioscience Cancels License Agreements with ADC Therapeutics | MT |
| Feb. 13 | Chiome Bioscience Inc. Announces Entrustment Agreement with Takeda Pharmaceutical Company Limited | CI |
Chiome Bioscience Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was JPY 169.4 million compared to JPY 128.57 million a year ago. Net loss was JPY 227.68 million compared to JPY 492.44 million a year ago.
Basic loss per share from continuing operations was JPY 4.7 compared to JPY 11.66 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -8.89% | 43.53M | |
| +1.51% | 42.75B | |
| +49.22% | 41.61B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B |
CHIOME BIOSCIENCE INC. 
